DEEP RESEARCH · AHNLAB·GENIANS
AhnLab and Genians: Two Axes of Zero Trust and AI Security
A value-versus-growth view of Korea's MLS, zero trust, and AI security cycle
0. Bottom line first
My takeaway is that AhnLab is a defensive value stock with KRW 280 billion of cash and an OT security option, while Genians is a growth stock backed by more than 60% NAC share and the ZTNA transition. Both are security-cycle plays, but the risk profiles differ.
Official fact: The source says Korea's security market is moving from physical network separation to MLS, while zero trust and AI security are rising together. AhnLab, founded in 1995, is expanding from V3 into the AhnLab PLUS integrated platform. Genians is framed as a network visibility and access-control company built on NAC, ZTNA, and EDR.
Interpretation: AhnLab offers downside support and an OT/ICS option. Genians has a more direct route from policy change to revenue growth. The source therefore proposes a barbell of 40% AhnLab and 60% Genians.
1. How MLS and zero trust change demand
| Grade | Data examples | Network model | Required technology | Primary beneficiaries |
|---|---|---|---|---|
| C(Classified) | National-security, defense, diplomacy, and investigation data | Physical separation maintained | High-performance firewall, one-way transfer, closed-network security | AhnLab TrusGuard/EPS, SK Shieldus |
| S(Sensitive) | Personal information and non-public administrative data | Logical separation allowed | ZTNA, VDI/DaaS | Genians ZTNA, Tilon, AhnLab vTrusGuard |
| O(Open) | Pseudonymized, public, and AI-use data | Internet connection allowed | CDR, CASB, EDR, RBI | Genians Cloud NAC, SoftCamp, Monitorapp |
Relaxing physical separation does not mean weaker security. It means more precise control by data importance. AhnLab is positioned for stable legacy C-grade demand, while Genians is more directly exposed to S- and O-grade identity and endpoint-based access control.
2. AhnLab: cash margin of safety plus OT option
AhnLab started with V3 but is now pursuing AhnLab PLUS across endpoint, network, cloud, OT/ICS, and blockchain. EPP/EDR, TrusGuard/XTG, and OT protocol-analysis technology acquired through Naonworks are central pieces.
About KRW 280bn cash
The source cites large cash and liquid financial assets at 3Q 2025, high relative to market value.
OT/ICS security
AhnLab CPS PLUS is presented as a beneficiary of smart factories and industrial-control security.
Margin pressure
Early investment in Cloudmate and Blockchain Company plus slow V3 growth may pressure operating margins.
3. Genians: from NAC to ZTNA
Genians is defined by network visibility and access control. The source cites more than 60% domestic NAC share and 20-plus years of endpoint identification data and DPI as its moat.
Interpretation: If VPN is replaced by ZTNA based on identity and endpoint posture, Genians has a natural upsell path from its NAC base. Risks are competition from Cisco and Palo Alto Networks and valuation sensitivity as a growth stock.
4. Technology fit comparison
| Trend | AhnLab | Genians | Assessment |
|---|---|---|---|
| Zero trust | Gateway-centered integrated platform, XTG firewall and VPN | Identity-centered ZTNA, NAC, micro-segmentation | Genians |
| AI security | 30 years of threat data and AhnLab AI PLUS | Endpoint behavior and identification data, EDR analytics | AhnLab |
| Cloud | Expands into cloud security and MSP | Cloud NAC focus | AhnLab |
| OT security | Physical control and protocol analysis via Naonworks | Endpoint access control focus | AhnLab |
5. Valuation
The source uses both DCF and relative valuation. Assumptions include risk-free rate of 3.5%, market risk premium of 6.0%, perpetual growth of 2.0%, and tax rate of 22%.
- AhnLab: Beta 0.75, WACC about 7.8%, revenue growth around 5% per year, operating margin recovering to 10% by 2027, and net cash of about KRW 280 billion.
- AhnLab value: operating value about KRW 520 billion, non-operating value about KRW 280 billion, equity value about KRW 800 billion, fair value about KRW 72,000 per share. Upside about 20% versus roughly KRW 60,000 at analysis time.
- Genians: Beta 1.2, WACC about 10.5%, three-year revenue CAGR of 15%, and operating margin maintained at 20-22%.
- Genians value: operating value about KRW 195 billion, net cash about KRW 30 billion, equity value about KRW 225 billion, fair value about KRW 22,500 per share. Upside about 25% versus roughly KRW 18,000 at analysis time.
| Metric | AhnLab | Genians | Implication |
|---|---|---|---|
| PER(2025E) | 12x-15x | 14x-17x | Genians receives a higher multiple for growth |
| EV/EBITDA | ~4.5x | ~10.1x | AhnLab's operating value excluding cash is priced very low |
| ROE | 8-9% | 17-19% | Genians has far higher capital efficiency |
| Dividend yield | ~2.0% | ~0.5% | AhnLab also has some dividend-stock appeal |
6. Investment strategy
The conclusion is that both can be bought at current levels, but investor style matters. Genians suits growth investors; AhnLab suits value and defensive investors.
- Genians: direct beneficiary of MLS and ZTNA, with re-rating potential if global expansion becomes visible. Target price KRW 22,500, upside 25%.
- AhnLab: deep value because roughly KRW 280 billion of cash is not fully reflected, with OT security as a future growth driver. Target price KRW 72,000, upside 20%.
- Portfolio view: a barbell of AhnLab 40% for stability and Genians 60% for structural growth alpha.
Sources
- Original blog: https://m.blog.naver.com/PostView.naver?blogId=star_of_self&logNo=224104351262
- Security market competitiveness review: https://drive.google.com/open?id=18nWu5iQX2duXbxBlLBO5T990ICyG7BR7Qx96QNDiSFg
- Genians investment report generation: https://drive.google.com/open?id=1BvqlrMrBngbgTV3Q2jZsD1d4ntG0t6-iCImm4nU4dXk
- Small-cap Value & Growth report: https://drive.google.com/open?id=1XT4VCcMW9rZByY99jKjH3k9g1JDvo2tZ